Your browser doesn't support javascript.
loading
Are persons living with diagnosed HIV capable of mounting a strong inflammatory response to the new coronavirus?
Maro, Anna; Rosenthal, Elizabeth M; Abdallah, Marie; Tesoriero, James; Dehovitz, Jack.
Afiliación
  • Maro A; Division of Infectious Diseases, NYC Health and Hospitals Kings County, Brooklyn, NY, USA.
  • Rosenthal EM; Center for Program Development, Implementation, Research and Evaluation, AIDS Institute, New York State Department of Health, Albany, NY, USA.
  • Abdallah M; Division of Infectious Diseases, NYC Health and Hospitals Kings County, Brooklyn, NY, USA.
  • Tesoriero J; Center for Program Development, Implementation, Research and Evaluation, AIDS Institute, New York State Department of Health, Albany, NY, USA.
  • Dehovitz J; Center for Collaborative HIV Research in Practice and Policy, University at Albany School of Public Health, State University of New York, Rensselaer, NY, USA.
Int J STD AIDS ; 34(13): 978-983, 2023 11.
Article en En | MEDLINE | ID: mdl-37498157
BACKGROUND: The impact of COVID-19 on persons living with diagnosed HIV (PLWDH) remains incompletely understood. It's unclear whether an impaired immune system offers protection against mounting cytokine storm. METHODS: Retrospective matched cohort study of COVID-19 hospitalized individuals in New York State (NYS). Medical records were abstracted and analyzed for 853 PLWDH hospitalized with COVID-19 in NYS and 1621 HIV-negative controls. Preexisting comorbidities and inflammatory markers measured within 24 h of hospital admission were abstracted. RESULTS: PLWDH were significantly less likely to have elevated inflammatory markers compared to matched controls. Elevated WBC occurred in 23.3% of PLWDH vs 30.1% of controls (p = .0002), elevated CRP in 37.4% of PLWDH vs 43.2% of controls (p = .03), elevated ferritin in 73.4% of PLWDH vs 78.9% of controls (p = .004). There was an inverse but not statistically significant relationship between the frequency of elevated inflammatory markers and HIV disease stage, with greatest percent of PLWDH with elevated WBC, LDH, CRP, and ferritin among PLWDH with HIV disease stage 1. CONCLUSION: PLWDH had lower inflammatory marker elevation during COVID-19 infection compared to matched controls. PLWDH with low CD4 were less likely to mount a cytokine storm in the setting of impaired immune function.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / COVID-19 Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Humans Idioma: En Revista: Int J STD AIDS Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / COVID-19 Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Humans Idioma: En Revista: Int J STD AIDS Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido